ArticleTherapeutic advances in respiratory disease

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.

Giovanna Elisiana Carpagnano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.